)
)
)
Illimis Therapeutics
Ilimis Therapeutics is a platform-based biotech company developing a chimeric fusion protein platform (GAIA) for Neurodegenerative/Immune diseases. GAIA is differentiated by its ability to address the concern of antibody-induced neuroinflammation.
Address
SeoulGangnam-gu
South Korea
)
){kind=logo}
)
){kind=logo}
){kind=logo}
)
)
)
)